-
Mashup Score: 1
Cognition of older women with early breast cancer did not decline in the first two years after treatment initiation, irrespective of ET. Our findings suggest that the fear of declining cognition does not justify the de-escalation of breast cancer treatment in older women.
Source: PubMedCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 8Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials - 1 year(s) ago
Abstract. As part of ongoing efforts to meaningfully improve recruitment, enrollment, and accrual of older adults into cancer clinical trials, the National Canc
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @myCARG: Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials https://t.co/YAUkWjuyVv @Gretche…
-
-
Mashup Score: 3Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials - 1 year(s) ago
Abstract. The workshop “Engaging Older Adults in Cancer Clinical Trials Conducted in the NCI Clinical Trials Network: Challenges and Opportunities” included a P
Source: OUP AcademicCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 3
Resilience, the ability to respond to stressors by maintaining or rapidly returning to normal homeostasis, serves as a new paradigm to improve the care of older adults. However, resilience research in oncology is nascent. We aimed to describe the current research landscape on physical, cognitive, and psychosocial resilience in older cancer patients.
Source: Journal of Geriatric OncologyCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 6ASH22 - 1 year(s) ago
Download the program for ASH22. Easily access event sessions, speakers, exhibitors, and organizer messages. Download the native app to personalize your schedule, take notes, share contacts, and more. Try the interactive web version More features available for iOS and Android …
Source: ativsoftware.comCategories: Hematologists1, Latest HeadlinesTweet-
RT @ROlinMD: Check out the 9th heme/aging workshop this year! You won’t want to miss https://t.co/vkLV9o4AgI #ASH22 @Ashley_Rosko1 @tany…
-
-
Mashup Score: 6Effects of a Geriatric Assessment Intervention on Patient-Reported Symptomatic Toxicity in Older Adults With Advanced Cancer - 2 year(s) ago
PURPOSE Providing a geriatric assessment (GA) summary with management recommendations to oncologists reduces clinician-rated toxicity in older patients with advanced cancer receiving treatment. This secondary analysis of a national cluster randomized clinical trial (ClinicalTrials.gov identifier: NCT02054741) aims to assess the effects of a GA intervention on symptomatic toxicity measured by…
Source: Journal of Clinical OncologyCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 11A scoping review of ageism towards older adults in cancer care - 2 year(s) ago
Ageism towards older adults with cancer may impact treatment decisions, healthcare interactions, and shape health/psychosocial outcomes. The purpose of this review is twofold: (1) To synthesize the literature on ageism towards older adults with cancer in oncology and (2) To identify interventions that address ageism in the healthcare context applicable to oncology.
Source: Journal of Geriatric OncologyCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 4Cancer and Aging Research Group - 2 year(s) ago
2022 CARinG Pilot Grant The Cancer and Aging Research Group (CARG) Infrastructure Grant is requesting applications for two pilot projects in the field of CARG Bulletin Board We have a new page to share relevant links from our newsletters and meetings. Click here…
Source: www.mycarg.orgCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1Conquering Cancer: Wilmot Takes Part in ASCO Meeting - 2 year(s) ago
The latest on Wilmot faculty and trainees who are participating in the year’s largest annual meeting for cancer specialists.
Source: URMC NewsroomCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 2Announced! Interim Associate Dean for Research - 2 year(s) ago
Dear Research Community, I am excited to announce that Jamy Ard, MD has agreed to serve as Interim Associate Dean for Research with an Enterprise-wide focus on clinical research and implementation. In this new role, which he will assume immediately, Dr. Ard will work…
Source: mailchi.mpCategories: Latest Headlines, Oncologists2Tweet
Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from … https://t.co/TYyy1czOpP Useful study for counselling patients. No meaningful decline at 2 years. @myCARG